Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $176.69 million. The enterprise value is $191.73 million.
Market Cap | 176.69M |
Enterprise Value | 191.73M |
Important Dates
The next estimated earnings date is Tuesday, July 16, 2024, before market open.
Earnings Date | Jul 16, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.62 million shares outstanding. The number of shares has increased by 2.37% in one year.
Shares Outstanding | 16.62M |
Shares Change (YoY) | +2.37% |
Shares Change (QoQ) | +0.83% |
Owned by Insiders (%) | 1.82% |
Owned by Institutions (%) | 69.91% |
Float | 10.54M |
Valuation Ratios
The trailing PE ratio is 16.61 and the forward PE ratio is 17.66.
PE Ratio | 16.61 |
Forward PE | 17.66 |
PS Ratio | 1.05 |
Forward PS | 1.31 |
PB Ratio | 1.37 |
P/FCF Ratio | 224.80 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.96, with an EV/FCF ratio of 243.94.
EV / Earnings | 18.38 |
EV / Sales | 1.14 |
EV / EBITDA | 9.96 |
EV / EBIT | 12.50 |
EV / FCF | 243.94 |
Financial Position
The company has a current ratio of 4.03, with a Debt / Equity ratio of 0.20.
Current Ratio | 4.03 |
Quick Ratio | 1.94 |
Debt / Equity | 0.20 |
Debt / EBITDA | 1.31 |
Debt / FCF | 31.98 |
Interest Coverage | 7.26 |
Financial Efficiency
Return on equity (ROE) is 8.40% and return on invested capital (ROIC) is 6.93%.
Return on Equity (ROE) | 8.40% |
Return on Assets (ROA) | 5.90% |
Return on Capital (ROIC) | 6.93% |
Revenue Per Employee | $314,655 |
Profits Per Employee | $19,466 |
Employee Count | 536 |
Asset Turnover | 0.95 |
Inventory Turnover | 2.75 |
Taxes
In the past 12 months, Ultralife has paid $2.79 million in taxes.
Income Tax | 2.79M |
Effective Tax Rate | 21.08% |
Stock Price Statistics
The stock price has increased by +115.62% in the last 52 weeks. The beta is 0.99, so Ultralife's price volatility has been similar to the market average.
Beta (5Y) | 0.99 |
52-Week Price Change | +115.62% |
50-Day Moving Average | 11.10 |
200-Day Moving Average | 9.06 |
Relative Strength Index (RSI) | 50.77 |
Average Volume (20 Days) | 150,958 |
Short Selling Information
The latest short interest is 60,279, so 0.36% of the outstanding shares have been sold short.
Short Interest | 60,279 |
Short Previous Month | 55,260 |
Short % of Shares Out | 0.36% |
Short % of Float | 0.57% |
Short Ratio (days to cover) | 0.77 |
Income Statement
In the last 12 months, Ultralife had revenue of $168.66 million and earned $10.43 million in profits. Earnings per share was $0.64.
Revenue | 168.66M |
Gross Profit | 43.23M |
Operating Income | 13.51M |
Pretax Income | 13.22M |
Net Income | 10.43M |
EBITDA | 19.24M |
EBIT | 15.33M |
Earnings Per Share (EPS) | $0.64 |
Balance Sheet
The company has $10.10 million in cash and $25.14 million in debt, giving a net cash position of -$15.04 million or -$0.90 per share.
Cash & Cash Equivalents | 10.10M |
Total Debt | 25.14M |
Net Cash | -15.04M |
Net Cash Per Share | -$0.90 |
Equity (Book Value) | 128.84M |
Book Value Per Share | 7.75 |
Working Capital | 70.93M |
Cash Flow
In the last 12 months, operating cash flow was $3.21 million and capital expenditures -$2.43 million, giving a free cash flow of $786,000.
Operating Cash Flow | 3.21M |
Capital Expenditures | -2.43M |
Free Cash Flow | 786,000 |
FCF Per Share | $0.05 |
Margins
Gross margin is 25.63%, with operating and profit margins of 8.01% and 6.19%.
Gross Margin | 25.63% |
Operating Margin | 8.01% |
Pretax Margin | 7.84% |
Profit Margin | 6.19% |
EBITDA Margin | 11.41% |
EBIT Margin | 9.09% |
FCF Margin | 0.47% |
Dividends & Yields
Ultralife does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.37% |
Shareholder Yield | -2.37% |
Earnings Yield | 5.91% |
FCF Yield | 0.44% |
Analyst Forecast
The average price target for Ultralife is $14.00, which is 31.70% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $14.00 |
Price Target Difference | 31.70% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Ultralife has an Altman Z-Score of 3.45 and a Piotroski F-Score of 6.
Altman Z-Score | 3.45 |
Piotroski F-Score | 6 |